SEARCH:   Advanced

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Brittenham, G. M. Search for Related Content PubMed Articles by Brittenham, G. M. Related Collections Related Article in Blood Online Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 June 2003, Vol. 101, No. 11, pp. 4231 Myocardial irony Iron-induced heart disease remains the most frequent cause of death in thalassemia major and a critical life-limiting complication of other transfusion-dependent disorders, hereditary hemochromatosis, and other forms of iron overload. Cardiac iron toxicity is insidious, characteristically remaining clinically covert until heart failure and arrhythmias abruptly appear. Early detection of patients at increased risk by endomyocardial biopsy is ineffective because iron is deposited heterogeneously in the heart. As summarized in a recent NIDDK workshop (Brittenham and Badman, Blood. 2003;101:15-19), magnetic resonance (MR) studies offer a potential noninvasive means of identifying patients with heart iron deposition. Use of MR to assess cardiac iron has been hindered because clinical MR instruments detect tissue iron indirectly by the magnetic effects of ferritin and hemosiderin iron on nearby hydrogen nuclei. Because a detailed theoretical understanding of these complex interactions is lacking, empirical efforts have used a variety of instruments, imaging sequences, and parameters. In this issue, Jensen and colleagues (page 4632) report the first repeated MR measurements of cardiac iron in transfused patients treated with deferoxamine. Using signal intensity ratios, they found increased cardiac iron (with one exception) only in patients with a liver iron concentration above a threshold concentration (350 µmol/g dry weight), as well as significant correlations between heart iron and serum ferritin concentration and, intriguingly, deferoxamine-induced urinary iron excretion. As the authors emphasize, other MR approaches (T2, T2*, magnetization transfer ratios) have yielded seemingly contradictory results (eg, no hepatic iron threshold for cardiac iron, no significant relationship with serum ferritin). Jensen and his colleagues, painstaking pioneers in the use of MR for studies of tissue iron, caution that clinical use of MR estimates of myocardial iron must await an "ironing out" of these apparent anomalies. Gary M. Brittenham Columbia University College of Physicians and Surgeons CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? Related Article in Blood Online: Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool Peter D. Jensen, Finn T. Jensen, Thorkil Christensen, Hans Eiskjær, Ulrik Baandrup, and Johan L. Nielsen Blood 2003 101: 4632-4639. [Abstract] [Full Text] [PDF] This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Brittenham, G. M. Search for Related Content PubMed Articles by Brittenham, G. M. Related Collections Related Article in Blood Online Social Bookmarking                   What's this?

	Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020